Correspondence on letter to the editor regarding “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma” |
Young Eun Chon1, Dong Yun Kim2, Hong Jae Chon3, Do Young Kim2 |
1Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea 3Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea |
|
Received: October 16, 2024 Accepted: October 20, 2024 *Young Eun Chon and Dong Yun Kim contributed equally to this work. |
|
|
|